European Perspectives on Incorporating New Prevention and Treatment Strategies Into HIV Care

On January 28, join us for the fourth and final installment in a series designed to address key areas of controversy and challenging patient management in HIV care!

In this live, 45-minute, CME/CE/CPE-certified Webinar,  Anne-Geneviève Marcelin, PharmD, PhD, and Jürgen K. Rockstroh, MD, will use case-based examples to provide expert guidance on incorporating new prevention and treatment strategies into HIV care.

Agenda

Program Overview (5 mins)

Case-Based Discussion (35 mins)

  • FTC/TAF as PrEP
  • Extended-Release Injectable CAB + RPV

Question and Answer Session (5 mins)

Faculty

Faculty
Anne-Geneviève Marcelin, PharmD, PhD

Faculty
Jürgen K. Rockstroh, MD

Professor of Medicine
University of Bonn
Bonn, Germany

Program Overview
A series of live Webinars during which expert faculty discuss current challenges and new developments in HIV care.

Goal Statement
The goal of this activity is to improve participants’ confidence and competence in incorporating best practices and emerging data into their HIV patient care strategies.

Target Audience 
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the management of patients at risk of or infected with HIV.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Consider the advantages and disadvantages of emerging strategies for prevention and treatment of HIV infection

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity or enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Pharmacist Continuing Education
CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-20-017-L01-P

Type of Activity: Knowledge

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.